While the aforementioned relative threats remain challenging to extrapolate to AAS users, and the absolute chance may be small – Particularly considering AAS customers are frequently younger than forty–fifty yrs of age – the chance might be compounded by other harmful effects of AAS on blood lipids and cardiac framework and performance. Hence